By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panelists agree that ASML's future growth is tied to the capital expenditure cycles of major chipmakers, with a significant risk being regulatory exposure and potential curbs on China sales. They also highlight the risk of a cyclical downturn in capex and the potential impact of Intel's foundry struggles on ASML's revenue.
Risk: Regulatory exposure and potential curbs on China sales
Opportunity: AI-driven demand lifting capex for EUV tools
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
ASML (NASDAQ: ASML) stock is soaring along with the semiconductor industry overall.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
*Stock prices used were the afternoon prices of June 3, 2026. The video was published on June 5, 2026.
Before you buy stock in ASML, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and ASML wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $443,191! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,258,838!
Now, it’s worth noting Stock Advisor’s total average return is 941% — a market-crushing outperformance compared to 206% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 7, 2026. *
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ASML. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"ASML's EUV monopoly and AI-driven capex tailwinds should drive upside, but macro downturns or export controls could unwind the premium quickly."
ASML still sits at the center of leading-edge chip fabrication, and AI-driven demand should lift capex for EUV tools. The article’s 'indispensable monopoly' framing is aggressive; ASML’s position is strong but not infinite, and the upshot depends on sustained wafer-fab spend from TSMC, Samsung, and Intel. Risks glossed over include a cyclical downturn in capex, which can be sharp if AI workloads normalize or supply chains reprice memory cycles, and policy limits on selling to China that could redirect or dampen long-run growth. Valuation may already reflect optimistic growth; any wobbly demand or margin pressure could compress multiples.
The strongest counter is that even a true monopoly on EUV is not immune to macro capex cycles; a credible slowdown in semiconductor capex or a subpar AI compute cycle could mute orders, and policy restrictions on China could tilt demand away from ASML's most profitable regions. If growth slows, the high multiple could contract quickly.
"ASML’s valuation is less a reflection of AI growth and more a hostage to the massive, lumpy capital expenditure cycles of a three-player foundry market."
ASML remains the gatekeeper of the semiconductor industry through its EUV (extreme ultraviolet) lithography monopoly. While the article functions as a lead-gen funnel for subscription services, the underlying reality is that ASML’s valuation is tethered to the capital expenditure cycles of TSMC, Intel, and Samsung. With a forward P/E often hovering in the 30x-40x range, the stock is priced for perfection. Investors must look past the 'AI hype' and monitor the High-NA EUV adoption rates. If logic density scaling slows or foundry utilization rates dip due to geopolitical trade restrictions on China, ASML’s margins will face immediate compression.
The bull case ignores the extreme concentration risk; if a single major foundry client pivots away from current lithography roadmaps or faces a sustained cyclical downturn, ASML’s lack of diversification becomes a structural liability.
"This is a subscription sales pitch masquerading as stock analysis; ASML may be a solid business, but this article provides zero evidence either way."
This article is not analysis—it's marketing. The piece asks 'Should you buy ASML?' then immediately pivots to selling Stock Advisor subscriptions using cherry-picked historical returns (Netflix +44,000%, Nvidia +125,000%). ASML itself receives zero fundamental scrutiny: no valuation metrics, no competitive moat assessment, no geopolitical risk (Dutch export controls on chip equipment to China are material and evolving). The 'soaring with semiconductors' opener is vague. We don't know ASML's current P/E, forward growth rate, or how it compares to historical averages. The exclusion from the 'top 10' list is presented as a red flag, but that's backwards reasoning—it's actually a sales tactic to create FOMO.
ASML genuinely does hold a quasi-monopoly on extreme ultraviolet (EUV) lithography equipment, and semiconductor capex cycles are accelerating; if the article had simply stated that with a valuation anchor, the bullish case would be real.
"The article supplies zero valuation data or demand forecasts, functioning mainly as a subscription funnel rather than an investment thesis."
This Motley Fool piece uses an ASML headline to funnel readers into a Stock Advisor subscription pitch, explicitly noting that ASML missed their latest top-10 list despite the firm's existing long position. No valuation metrics, EUV shipment forecasts, or margin trends are supplied, only past performance examples from Netflix and Nvidia. The June 2026 timing and disclosure that the firm recommends ASML elsewhere create internal tension: the article simultaneously downplays near-term appeal while maintaining ownership. Readers receive marketing volume rather than semiconductor-cycle insight on lithography demand or China exposure risks.
Motley Fool's documented 941% average returns since inception could still justify the subscription push even if the specific ASML framing is thin, and their disclosed long position may reflect a longer-term hold rather than a current buy signal.
"Regulatory exposure could erode ASML's moat and margins, compressing the stock multiple even if AI-driven demand remains healthy."
Claude, I agree the piece feels marketing-light, but a bigger overlooked risk is regulatory exposure. Dutch export controls and potential U.S.-led restrictions could curb China sales and reallocate capex away from ASML, hit margins, and compress the stock multiple even if AI-driven demand remains healthy. The moat isn’t immune to policy sequencing risk, which could matter more than near-term AI hype. That risk could show up in 2026–28 as orders slip or re-price.
"Intel's internal foundry instability poses a greater near-term risk to ASML's order book than China-related export policy."
ChatGPT, your focus on China policy ignores the 'Intel factor.' Intel’s foundry struggles are a more immediate threat to ASML’s 2025-26 revenue than export controls. If Intel delays its 18A process or shifts to external foundries, ASML loses its primary non-TSMC volume driver. While you worry about geopolitical sequencing, the real risk is a domestic capex contraction from a major client facing structural insolvency or a massive pivot in their internal manufacturing strategy.
"Concurrent China policy tightening, Intel capex weakness, and TSMC normalization in 2025-26 create a compound margin squeeze that single-risk analysis misses."
Gemini's Intel risk is real but overstated. Intel's foundry capex is ~$20B annually—material but not ASML's majority revenue. The larger blind spot: both China policy AND Intel weakness could compound simultaneously in 2025-26, creating a double-margin squeeze. TSMC remains ASML's revenue anchor, but if TSMC capex normalizes post-AI while Intel stumbles and China orders face restrictions, ASML's growth narrative collapses faster than either risk in isolation. That timing convergence is the real tail risk.
"Samsung memory cycles and TSMC utilization could offset the Intel-China double squeeze more than assumed."
Claude's compounding tail-risk claim assumes simultaneous hits without offsets. TSMC's ongoing AI node ramps could absorb Intel's foundry shortfalls if utilization stays elevated, while Samsung memory cycles have historically driven larger ASML order swings than Intel alone. The panel still omits any shipment or backlog data that would quantify whether these buffers hold in 2025-26.
The panelists agree that ASML's future growth is tied to the capital expenditure cycles of major chipmakers, with a significant risk being regulatory exposure and potential curbs on China sales. They also highlight the risk of a cyclical downturn in capex and the potential impact of Intel's foundry struggles on ASML's revenue.
AI-driven demand lifting capex for EUV tools
Regulatory exposure and potential curbs on China sales